Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHAT | P28329 | 5/20 | 0.46 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.44 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | RXRA | P19793 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.43 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.43 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.43 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.43 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.43 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.43 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylamine SCHEMBL27560497 | 0.96 | GRIN2D (0.44) | CHATMTNR1AMTNR1BALDH1A1CYP2A6 | |
| SCHEMBL108120 | 0.85 | CHAT (0.43) | CHATMTNR1AMTNR1BALDH1A1CYP2A6 | |
| SCHEMBL303613 | 0.82 | CHAT (0.48) | CHATMTNR1AMTNR1BRXRAKDM4E | |
| SCHEMBL615455 | 0.81 | SMPD2 (0.51) | CHATMTNR1AMTNR1BRXRAPTGS1 | |
| SCHEMBL615456 | 0.81 | SMPD2 (0.51) | CHATMTNR1AMTNR1BRXRAPTGS1 | |
| SCHEMBL10675341 | 0.81 | CYP1A2 (0.46) | CHATMTNR1AMTNR1BRXRAKDM4E | |
| SCHEMBL304871 | 0.81 | ALDH1A1 (0.44) | ALDH1A1CYP2A6KDM4EPTGS1PTGS2 | |
| SCHEMBL304242 | 0.81 | CHAT (0.50) | CHATMTNR1AMTNR1BALDH1A1KDM4E | |
| SCHEMBL5254576 | 0.80 | RXRA (0.43) | CHATMTNR1AMTNR1BALDH1A1CYP2A6 | |
| SCHEMBL7795350 | 0.80 | RXRA (0.43) | CHATMTNR1AMTNR1BALDH1A1CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2176 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116848094-A | Tertiary amine lipid compounds and uses thereof | 华南理工大学 | 2023-10-03 | — | — | CN | claimed |
| WO-2023125184-A1 | TERTIARY AMINE LIPID COMPOUND AND USE THEREOF | 华南理工大学 | 2023-07-06 | — | — | WO | claimed |
| CN-116120919-A | Triplet-triplet annihilation up-conversion luminescent material based on thermal activation and preparation and application thereof | 中国科学院理化技术研究所 | 2023-05-16 | — | — | CN | claimed |
| US-11530234-B2 | CD73 inhibitors and pharmaceutical uses thereof | Risen (Suzhou) Pharma Tech Co., Ltd. (CN) | 2022-12-20 | — | — | US | claimed |
| CN-111233786-B | Benzene sulfonamide compound containing five-membered heterocycle and preparation method and application thereof | 中国人民解放军军事科学院军事医学研究院 | 2021-11-26 | — | — | CN | claimed |
| EP-3849992-A1 | CD73 INHIBITORS AND PHARMACEUTICAL USES THEREOF | Risen (Suzhou) Pharma Tech Co., Ltd. (CN) | 2021-07-21 | — | — | EP | claimed |
| US-11059818-B2 | Triazolopyridine inhibitors of myeloperoxidase | BRISTOL-MYERS SQUIBB COMPANY (US) | 2021-07-13 | — | — | US | claimed |
| US-11008317-B2 | Triazolopyridine inhibitors of myeloperoxidase and/or EPX | BRISTOL-MYERS SQUIBB COMPANY (US) | 2021-05-18 | — | — | US | claimed |
| US-20210139526-A1 | CD73 INHIBITORS AND PHARMACEUTICAL USES THEREOF | RISEN (SUZHOU) PHARMA TECH Co.,Ltd. (CN) | 2021-05-13 | — | — | US | claimed |
| CN-112771061-A | CD73 inhibitor and pharmaceutical application thereof | 润佳（苏州）医药科技有限公司 | 2021-05-07 | — | — | CN | claimed |
| US-6287794-B1 | Factor Vlla inhibitors | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-09-11 | — | — | US | claimed |
| EP-1114061-A1 | FACTOR VIIa INHIBITORS | Aventis Pharma Deutschland GmbH (DE) | 2001-07-11 | — | — | EP | claimed |
| WO-2000015658-A1 | FACTOR VIIa INHIBITORS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2000-03-23 | — | — | WO | claimed |
| EP-0319986-B1 | Anti-plasmin depressant | NIPPON SHINYAKU CO LTD (JP) | 1997-03-12 | — | — | EP | claimed |
| US-5134128-A | Immunosuppressive and antiproliferative activity for psoriasis and calcium homeostasis | ALLERGAN, INC. (US) | 1992-07-28 | — | — | US | claimed |
| EP-0338946-B1 | Sweetening agents which derive from the acides l-aspartic and l-glutamotic-n-hydrocarbonés | NOFRE, Claude (FR) | 1992-07-01 | — | — | EP | claimed |
| US-4935517-A | STABILITY, INTENSITY | UNIVERSITE CLAUDE BERNARD (FR) | 1990-06-19 | — | — | US | claimed |
| EP-0372941-A2 | Anti-inflammatory 5-hydroxy-2-furanones | ALLERGAN, INC (US) | 1990-06-13 | — | — | EP | claimed |
| EP-0338946-A1 | Sweetening agents which derive from the acides l-aspartic and l-glutamotic-n-hydrocarbonés | NOFRE, Claude (FR) | 1989-10-25 | — | — | EP | claimed |
| EP-0153261-B1 | ESTERS FROM THE FAMILY OF THE N-PHOSPHONOMETHYLGLYCINE AND THEIR USE FOR THE PREPARATION OF KNOWN HERBICIDES | RHONE-POULENC AGROCHIMIE (FR) | 1989-01-25 | — | — | EP | claimed |